Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 2—February 2011
Research

Severe Cases of Pandemic (H1N1) 2009 in Children, Germany

Mathias AltmannComments to Author , Lena Fiebig, Jana Soyka, Rüdiger von Kries, Manuel Dehnert, and Walter Haas
Author affiliations: Author affiliations: Robert Koch Institute, Berlin, Germany (M. Altmann, L. Fiebig, J. Soyka, M. Dehnert, W. Haas); Ludwig-Maximilians-Universität, Munich, Germany (R. von Kries)

Main Article

Table 4

Treatment administered to children with severe pandemic (H1N1) 2009, Germany, 2009–2010*

Survivors Nonsurvivors Subtotal p value OR (95% CI)
Oseltamivir 53/88 (60) 2/4 (50) 44/74 (59) 7/10 (70) 51/84 (61) 0.733 1.6 (0.3–10.2)
Antimicrobial drug 80/91 (88) 4/4 (100) 67/77 (87) 9/10 (90) 76/87 (87) 1 1.3 (0.2–64.7)
Catecholamine 28/85 (33) 0/4 (0) 20/70 (29) 8/11 (73) 28/81 (35) 0.007 6.7 (1.4–41.8)
Mechanical ventilation 56/90 (62) 0/4 (0) 45/75 (60) 11/11 (100) 56/86 (65) 0.007 NA (1.8–NA)

*Values are no. positive/no with available information (%) except as indicated. PICU, pediatric intensive care unit; OR, odds ratio; CI, confidence interval, NA, not applicable.

Main Article

Page created: July 13, 2011
Page updated: July 13, 2011
Page reviewed: July 13, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external